GB201204985D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB201204985D0
GB201204985D0 GBGB1204985.4A GB201204985A GB201204985D0 GB 201204985 D0 GB201204985 D0 GB 201204985D0 GB 201204985 A GB201204985 A GB 201204985A GB 201204985 D0 GB201204985 D0 GB 201204985D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1204985.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Priority to GBGB1204985.4A priority Critical patent/GB201204985D0/en
Publication of GB201204985D0 publication Critical patent/GB201204985D0/en
Priority to PCT/EP2013/055878 priority patent/WO2013139882A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
GBGB1204985.4A 2012-03-21 2012-03-21 Compounds Ceased GB201204985D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1204985.4A GB201204985D0 (en) 2012-03-21 2012-03-21 Compounds
PCT/EP2013/055878 WO2013139882A1 (en) 2012-03-21 2013-03-21 Pyrazolopyridines for treatment of parkinsons disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1204985.4A GB201204985D0 (en) 2012-03-21 2012-03-21 Compounds

Publications (1)

Publication Number Publication Date
GB201204985D0 true GB201204985D0 (en) 2012-05-02

Family

ID=46052318

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1204985.4A Ceased GB201204985D0 (en) 2012-03-21 2012-03-21 Compounds

Country Status (2)

Country Link
GB (1) GB201204985D0 (en)
WO (1) WO2013139882A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2867236B1 (en) 2012-06-29 2017-06-14 Pfizer Inc Novel 4-(substituted-amino)-7h-pyrrolo[2,3-d]pyrimidines as lrrk2 inhibitors
JP6487921B2 (en) 2013-12-17 2019-03-20 ファイザー・インク Novel 3,4-disubstituted-1H-pyrrolo [2,3-b] pyridines and 4,5-disubstituted-7H-pyrrolo [2,3-c] pyridazines as LRRK2 inhibitors
AU2015210593A1 (en) 2014-01-29 2016-07-07 Glaxosmithkline Intellectual Property Development Limited Compounds
JP6474826B2 (en) * 2014-01-29 2019-02-27 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ Compound
RU2722149C1 (en) 2015-09-14 2020-05-27 Пфайзер Инк. New derivatives of imidazo [4,5-c] quinolines and imidazo [4,5-c] [1,5] naphthyridines as lrrk2 inhibitors
KR20220124275A (en) 2016-06-07 2022-09-13 자코바이오 파마슈티칼스 컴퍼니 리미티드 Novel heterocyclic derivatives useful as SHP2 inhibitors
EP3472171A4 (en) 2016-06-15 2019-12-18 Suzhou Yabao Pharmaceutical R&D Co., Ltd. Substituted tricyclic herteocyclic compounds and use thereof
MX2019011330A (en) 2017-03-23 2020-02-05 Jacobio Pharmaceuticals Co Ltd Novel heterocyclic derivatives useful as shp2 inhibitors.
CN111615514B (en) * 2018-01-18 2022-10-11 奥瑞生物药品公司 Substituted pyrazolo [4,3-C ] pyridine compounds as RET kinase inhibitors
CN111630054B (en) 2018-01-18 2023-05-09 奥瑞生物药品公司 Substituted pyrazolo [3,4-d ] pyrimidine compounds as RET kinase inhibitors
ES2738911A1 (en) 2018-07-25 2020-01-27 Consejo Superior Investigacion PROCEDURE FOR DEPOSITING ELEMENTS ON A SUBSTRATE OF INTEREST AND DEVICE (Machine-translation by Google Translate, not legally binding)
ES2744304B2 (en) 2018-08-24 2020-06-22 Consejo Superior Investigacion LRRK2 inhibitor compounds and their use for the treatment of neurodegenerative diseases
WO2023076404A1 (en) 2021-10-27 2023-05-04 Aria Pharmaceuticals, Inc. Methods for treating systemic lupus erythematosus
TW202342019A (en) * 2022-02-25 2023-11-01 大陸商蘇州亞寶藥物研發有限公司 Substituted fused cyclic compound and pharmaceutical composition, preparation method and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
AU2010224693B2 (en) 2009-03-19 2016-07-28 Lifearc Compounds
GB201008134D0 (en) 2010-05-14 2010-06-30 Medical Res Council Technology Compounds
GB201015949D0 (en) * 2010-09-22 2010-11-03 Medical Res Council Technology Compounds

Also Published As

Publication number Publication date
WO2013139882A1 (en) 2013-09-26

Similar Documents

Publication Publication Date Title
IL268013A (en) Tetrahydropyrazolopyrimidine compounds
HK1245780B (en) Imidazopyrrolidinone compounds
IL237341A0 (en) Pro-neurogenic compounds
GB201209138D0 (en) Compounds
GB201214750D0 (en) Compounds
GB201215357D0 (en) Compounds
EP2887803A4 (en) Pro-neurogenic compounds
HK1206726A1 (en) Imidazotriazinone compounds
GB201204985D0 (en) Compounds
GB201204125D0 (en) Compounds
PL2836495T3 (en) Tetrahydropyrrolothiazine compounds
HK1211283A1 (en) Compounds
GB201209096D0 (en) Compounds
HK1206356A1 (en) Lpar - substituted cyanopyrazole compounds lpar-
GB201219820D0 (en) Compounds
GB201217310D0 (en) Compounds
GB201223429D0 (en) Compounds
GB201220029D0 (en) Compounds
GB201219819D0 (en) Compounds
GB201218799D0 (en) Compounds
GB201218776D0 (en) Compounds
GB201218774D0 (en) Compounds
GB201218758D0 (en) Compounds
GB201218018D0 (en) Compounds
GB201217311D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)